Previous Close | 5.40 |
Open | 5.44 |
Bid | 0.00 x 1300 |
Ask | 0.00 x 800 |
Day's Range | 5.16 - 5.44 |
52 Week Range | 4.00 - 10.13 |
Volume | |
Avg. Volume | 87,804 |
Market Cap | 274.286M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.05 |
Earnings Date | Nov 10, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 10.25 |
When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...
Thank you for joining Thorne HealthTech's second quarter 2022 earnings call. With me today to share our results are Paul Jacobson, our CEO; and Bryan Conley, our CFO. Tom McKenna, our COO; and Michelle Crow, our chief Marketing officer are also available for questions.
Thorne HealthTech, Inc. ("Thorne HealthTech", "Thorne" or the "Company") (NASDAQ: THRN), a leader in developing personalized, innovative solutions to help people live healthier, longer lives, today announced its financial results for the second quarter ended June 30, 2022.